Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 9 of 9 entries
View as:

A Study to Evaluate Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Multiple Doses of VIS954

Phase: N/A Priority: Normal
NCT ID: NCT06937593 Org: User:
Start: 03/13/25 End: 02/13/26 Due: 02/13/27

Study of Efficacy and Safety of IV VIS410 Plus Oseltamivir Versus Oseltamivir in Hospitalized Adults With Influenza A

Phase: N/A Priority: Normal
NCT ID: NCT03040141 Org: User:
Start: 01/03/18 End: 11/22/18 Due: 11/22/19

Influenza Challenge Study of VIS410 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02468115 Org: User:
Start: 05/31/15 End: 02/29/16 Due: 02/28/17

Study of an Investigational Monoclonal Antibody, VIS410, in Subjects With Uncomplicated Influenza A

Phase: N/A Priority: Normal
NCT ID: NCT02989194 Org: User:
Start: 01/06/17 End: 10/27/17 Due: 10/27/18

A Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of VIS954 in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT06212804 Org: User:
Start: 11/22/23 End: 07/22/24 Due: 07/22/25

Safety and Efficacy Study of VIS649 for IgA Nephropathy

Phase: N/A Priority: Normal
NCT ID: NCT04287985 Org: User:
Start: 07/20/20 End: 06/18/23 Due: 06/18/24

A Study of VIS410 to Assess Safety and Pharmacokinetics

Phase: N/A Priority: Normal
NCT ID: NCT02045472 Org: User:
Start: 09/30/14 End: 05/31/15 Due: 05/31/16

First in Human Study to Assess Safety of VIS649 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03719443 Org: User:
Start: 10/09/18 End: 08/10/19 Due: 08/10/20

A Study to Evaluate the Safety, PK and PD of VIS171 in Participants (Healthy and with Autoimmune Disease)

Phase: N/A Priority: Normal
NCT ID: NCT05418101 Org: User:
Start: 04/28/22 End: 03/13/24 Due: 03/13/25